Market Overview:
The global allopurinol tablets market is expected to register a CAGR of 5.5% during the forecast period, 2018-2030. The market growth can be attributed to the increasing prevalence of gout and kidney stones across the globe. Additionally, rising awareness about allopurinol tablets as a treatment for gout and kidney stones is also contributing to the growth of this market. Based on type, the global allopurinol tablets market has been segmented into 100 mg and 300 mg segments. The 100 mg segment is expected to account for a larger share of the global allopurinol tablets market in 2018, owing to its lower price point as compared to 300 mg variants. However, with increasing awareness about benefits associated with use of higher dosage variants (300 mg), the 300 mg segment is projected to register a higher CAGR during the forecast period. Based on application,the global allopurinol tabletsmarket has been divided into gout and kidney stones segments.
Product Definition:
Allopurinol Tablets is a medicine which is used to prevent gout attacks and to lower the levels of uric acid in the blood.
100 mg:
Allopurinol is a drug used to treat gout and xerosis. It works by reducing the amount of uric acid in the body. Uric acid when present in high amounts causes pain, swelling, and redness of skin; it can also lead to kidney stones or renal tubular acidosis (RTAs) which is a serious medical condition where part of the kidney function gets damaged.
300 mg:
300 mg is used in the treatment of gout, rheumatoid arthritis and osteoarthritis. 300 mg Allopurinol Tablets is also used as a maintenance therapy for gout and rheumatoid arthritis. Increasing prevalence of these diseases has led to an increase in demand for 300 mg Allopurinol Tablets market globally. According to Arthritis Foundation, it was estimated that over 54 million people were suffering from arthritis in U.
Application Insights:
The gout segment held the largest share of over 70.0% in 2017 in terms of revenue as well as volume. The high share is attributed to the increasing prevalence of gout and rising awareness about allopurinol tablets for treating gouty arthritis. According to a research study, published in 2018 by NCBI, it is estimated that around 1:40 men above 60 years have been diagnosed with gout while another study states that around 1:50 adults are suffering from acute attacks of GOUT every year across the world.
The kidney stones application segment is anticipated to witness lucrative growth during the forecast period owing to an increase in stone formation among both males.
Regional Analysis:
Asia Pacific was the largest regional market in 2017 and is expected to maintain its position during the forecast period. This can be attributed to increasing product consumption, rising incidence of gout and kidney stones, and growing healthcare expenditure in emerging economies such as India, China, South Korea & Japan. In addition, increasing R&D activities by Allopurinol Tablets manufacturers coupled with government support are also driving the market growth in this region. For instance; In January 2018; Indian Council of Medical Research (ICMR) launched a national project on drug-to-drug interaction studies funded by an anonymous donor through crowd sourcing platform ‘Indigo Donate’.
Growth Factors:
- Increasing prevalence of gout and other hyperuricemia conditions: The global allopurinol tablets market is expected to benefit from the increasing prevalence of gout and other hyperuricemia conditions. This is mainly because allopurinol is the most commonly prescribed medication for the treatment of these conditions.
- Rising awareness about the benefits of allopurinol tablets: There has been a rise in awareness about the benefits of allopurinol tablets in recent years, which is likely to drive demand for these products in the coming years.
- Growing number of product approvals: The global allopurinol tablets market is expected to benefit from an increasing number of product approvals in future, as this will lead to an increase in availability of these products across regions.
- rising geriatric population: The global geriatric population is growing at a rapid pace, and this is expected to create significant growth opportunities for players operating in the global allopurinol tablets market over the forecast period.
Scope Of The Report
Report Attributes
Report Details
Report Title
Allopurinol Tablets Market Research Report
By Type
100 mg, 300 mg
By Application
Gout, Kidney Stones
By Companies
Casper Pharma, Dr. Reddys Laboratories, Teva, Zydus Pharmaceuticals, Mylan, Sun Pharmaceutical, APOTEX, NorthStar Healthcare, Ipca Laboratories, Accord Healthcare, Casper Pharma
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
136
Number of Tables & Figures
96
Customization Available
Yes, the report can be customized as per your need.
Global Allopurinol Tablets Market Report Segments:
The global Allopurinol Tablets market is segmented on the basis of:
Types
100 mg, 300 mg
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Gout, Kidney Stones
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Casper Pharma
- Dr. Reddys Laboratories
- Teva
- Zydus Pharmaceuticals
- Mylan
- Sun Pharmaceutical
- APOTEX
- NorthStar Healthcare
- Ipca Laboratories
- Accord Healthcare
- Casper Pharma
Highlights of The Allopurinol Tablets Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 100 mg
- 300 mg
- By Application:
- Gout
- Kidney Stones
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Allopurinol Tablets Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Allopurinol tablets are a medication used to treat gout. They work by reducing the amount of uric acid in the blood.
Some of the major companies in the allopurinol tablets market are Casper Pharma, Dr. Reddys Laboratories, Teva, Zydus Pharmaceuticals, Mylan, Sun Pharmaceutical, APOTEX, NorthStar Healthcare, Ipca Laboratories, Accord Healthcare, Casper Pharma.
The allopurinol tablets market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Allopurinol Tablets Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Allopurinol Tablets Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Allopurinol Tablets Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Allopurinol Tablets Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Allopurinol Tablets Market Size & Forecast, 2020-2028
4.5.1 Allopurinol Tablets Market Size and Y-o-Y Growth
4.5.2 Allopurinol Tablets Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 100 mg
5.2.2 300 mg
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Gout
6.2.2 Kidney Stones
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Allopurinol Tablets Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Allopurinol Tablets Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 100 mg
9.6.2 300 mg
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Gout
9.10.2 Kidney Stones
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 100 mg
10.6.2 300 mg
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Gout
10.10.2 Kidney Stones
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 100 mg
11.6.2 300 mg
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Gout
11.10.2 Kidney Stones
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 100 mg
12.6.2 300 mg
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Gout
12.10.2 Kidney Stones
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 100 mg
13.6.2 300 mg
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Gout
13.10.2 Kidney Stones
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Allopurinol Tablets Market: Competitive Dashboard
14.2 Global Allopurinol Tablets Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Casper Pharma
14.3.2 Dr. Reddys Laboratories
14.3.3 Teva
14.3.4 Zydus Pharmaceuticals
14.3.5 Mylan
14.3.6 Sun Pharmaceutical
14.3.7 APOTEX
14.3.8 NorthStar Healthcare
14.3.9 Ipca Laboratories
14.3.10 Accord Healthcare
14.3.11 Casper Pharma
